Alnylam Pharmaceuticals · Cambridge, MA · $145500 - $195500 per hour · Full Time
Overview
We are looking for an experienced and talented Business Account Executive (BAE) to commercially represent GIVLAARIand OXLUMO in the United States and have a significant impact on the lives of AHP patients. AHP's represent a sub-group of Porphyrias, characterized by the occurrence of neuro-visceral attacks with or without cutaneous manifestations. AHP's include four disorders: acute intermittent porphyria (the most common), variegate porphyria, hereditary coproporphyria, and a genetic deficit of delta-aminolaevulinic acid dehydratase. PH1 is a
